Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients
Simplified diagram of methodology. Blood samples were collected from 45 patients with breast cancer (BC): 30 were luminal A and 15 were triple-negative breast cancer patients (TNBC). Peripheral blood mononuclear cells (PBMCs) were isolated from blood and stored at −80 °C for future use. Monocytes were extracted from PBMCs using a MojoSort monocyte isolation kit and then differentiated into tumor-associated macrophages (TAMs). Thymoquinone (TQ) stock solution was prepared in dimethyl sulfoxide (DMSO) and was diluted with fresh culture media just before use. According to the literature, 20, 50, and 100 µM concentrations were prepared. PBMCs and TAMs were cultured with the aforementioned TQ concentrations for 24, 48, and 72 h. RNA isolation was conducted with RNeasy Mini Kit (QIAGEN) and then converted into cDNA in the thermocycler. Finally, RT-PCR was used to quantify calreticulin, NLRP3, PYCARD, caspase-1, and IL-1β. Relative Quantitation (RQ) values were calculated and plotted on the Y-axis against TQ concentrations. The cell culture supernatants were used to measure the secreted protein levels of IL-1β and sPD-L1 via ELISA. The expression and protein levels were compared to the DMSO control. All experiments were performed in triplicate and data were expressed as the mean ± standard deviation. Statistical analysis was performed using the GraphPad Prism software version 9.1.1. The data were analyzed using one-way ANOVA, Dunnett’s multiple comparisons, and unpaired t-test.
Publication
Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients. (2023) Sawsan Elgohary, et al. Int J Mol Sci. 2023 Sep;24(18):14254. Figure: F9.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Danio rerio | Vertebrates | CALR | CALR | ncbigene_symbol | calr | 325317 |
| Danio rerio | Vertebrates | CALR | CALR | ncbigene_synonym | calr3a | 30248 |
| Danio rerio | Vertebrates | PYCARD | PYCARD | ncbigene_symbol | pycard | 57923 |
| Danio rerio | Vertebrates | NLRP3 | NLRP3 | ncbigene_symbol | nlrp3 | 567964 |
| Danio rerio | Vertebrates | GAPDH | GAPDH | ncbigene_symbol | gapdh | 317743 |
| Danio rerio | Vertebrates | GAPDH | GAPDH | ncbigene_synonym | gapdhs | 406367 |
| Danio rerio | Vertebrates | IL-10 | IL10 | ncbigene_symbol | il10 | 553957 |
| Danio rerio | Vertebrates | IL-4, | IL-4 | ncbigene_synonym | il13 | 794053 |
| Danio rerio | Vertebrates | IL-4, | IL-4 | ncbigene_synonym | il4 | 100188894 |
| Homo sapiens | Primates | CALR | CALR | ncbigene_symbol | CALR | 811 |
| Homo sapiens | Primates | PYCARD | PYCARD | ncbigene_symbol | PYCARD | 29108 |
| Homo sapiens | Primates | NLRP3 | NLRP3 | ncbigene_symbol | NLRP3 | 114548 |
| Homo sapiens | Primates | GAPDH | GAPDH | ncbigene_symbol | GAPDH | 2597 |
| Homo sapiens | Primates | GAPDH | GAPDH | ncbigene_synonym | GAPDHP44 | 100240709 |
| Homo sapiens | Primates | IL-10 | IL-10 | ncbigene_synonym | IL10 | 3586 |
| Homo sapiens | Primates | IL-4, | IL-4 | ncbigene_synonym | IL4 | 3565 |
| Homo sapiens | Primates | M-CSF,TCM | MCSF | ncbigene_synonym | CSF1 | 1435 |
| Homo sapiens | Primates | IL-18 | IL-18 | ncbigene_synonym | IL18 | 3606 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Thymoquinone | thymoquinone | mesh:C003466 | thymoquinone | chebi:113532 |
| DMSO | Dimethyl Sulfoxide | mesh:D004121 | dimethyl sulfoxide | chebi:28262 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|